To make a long story short, blocking CCR5 interfer

To make a long story short, blocking CCR5 interferes with a wide variety of immune processes that cancer hijacks to cause tumor growth and proliferation.

Quote:

---

For example, EMT has been associated with PD-L1 expression, particularly in lung cancer. Increased levels of PD-L1 suppresses the immune system which allows the cancer to spread more easily.

---

Which is why in an earlier post responding to our use with Keytruda I thought it unnecessary.